ArticleAging2021

MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts.

Kaibin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.